| Applications: |
Immunodepletion/Immunocompetition |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
TYRO3 Blocking Peptide for STJ503445 is synthetically produced from the 800-850 sequence and is suitable for use in western blot applications. |
| Formulation: |
Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Storage Instruction: |
Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
| Gene Symbol: |
TYRO3 |
| Gene ID: |
7301 |
| Uniprot ID: |
TYRO3_HUMAN |
| Immunogen Region: |
800-850 |
| Specificity: |
This blocking peptide is recommended for use in combination with TYRO3 antibody, STJ503445 |
| Immunogen: |
Synthetic peptide taken within amino acid reigon 800-850 on human Tyrosine-protein kinase receptor TYRO3 protein. |
| Tissue Specificity | Abundant in the brain and lower levels in other tissues. |
| Post Translational Modifications | Autophosphorylated. |
| Function | Receptor tyrosine kinase that transduces signals from the extracellular matrix into the cytoplasm by binding to several ligands including TULP1 or GAS6. Regulates many physiological processes including cell survival, migration and differentiation. Ligand binding at the cell surface induces dimerization and autophosphorylation of TYRO3 on its intracellular domain that provides docking sites for downstream signaling molecules. Following activation by ligand, interacts with PIK3R1 and thereby enhances PI3-kinase activity. Activates the AKT survival pathway, including nuclear translocation of NF-kappa-B and up-regulation of transcription of NF-kappa-B-regulated genes. TYRO3 signaling plays a role in various processes such as neuron protection from excitotoxic injury, platelet aggregation and cytoskeleton reorganization. Also plays an important role in inhibition of Toll-like receptors (TLRs)-mediated innate immune response by activating STAT1, which selectively induces production of suppressors of cytokine signaling SOCS1 and SOCS3. (Microbial infection) Acts as a receptor for lassa virus and lymphocytic choriomeningitis virus, possibly through GAS6 binding to phosphatidyl-serine at the surface of virion envelope. (Microbial infection) Acts as a receptor for Ebolavirus, possibly through GAS6 binding to phosphatidyl-serine at the surface of virion envelope. |
| Peptide Name | Tyrosine-Protein Kinase Receptor Tyro3Tyrosine-Protein Kinase BykTyrosine-Protein Kinase DtkTyrosine-Protein Kinase RseTyrosine-Protein Kinase SkyTyrosine-Protein Kinase Tif |
| Cellular Localisation | Cell MembraneSingle-Pass Type I Membrane Protein |
| Alternative Peptide Names | Tyrosine-Protein Kinase Receptor Tyro3 proteinTyrosine-Protein Kinase Byk proteinTyrosine-Protein Kinase Dtk proteinTyrosine-Protein Kinase Rse proteinTyrosine-Protein Kinase Sky proteinTyrosine-Protein Kinase Tif proteinTYRO3 proteinBYK proteinDTK proteinRSE proteinSKY proteinTIF protein |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
